Search

Your search keyword '"Kyra A Gelderman"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Kyra A Gelderman" Remove constraint Author: "Kyra A Gelderman"
49 results on '"Kyra A Gelderman"'

Search Results

1. Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma

2. EXOME SEQUENCING REVEALS PRIMARY IMMUNODEFICIENCIES IN CHILDREN WITH COMMUNITY-ACQUIRED PSEUDOMONAS AERUGINOSA SEPSIS

Catalog

Books, media, physical & digital resources

3. A new arthritis therapy with oxidative burst inducers.

4. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases

5. C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia

6. Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool For Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

8. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis

9. Analytical validation of the Hevylite assays for M-protein quantification

10. Increased IgA Glycoprotein-2 Specic Antibody Titres in Refractory Celiac Disease

11. Dendritic Cells as a Tool to Induce Transplantation Tolerance: Obstacles and Opportunities

12. CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species

13. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species

14. Induction of Donor-Specific T-Cell Hyporesponsiveness Using Dexamethasone-Treated Dendritic Cells in Two Fully Mismatched Rat Kidney Transplantation Models

15. Complement production and regulation by dendritic cells: Molecular switches between tolerance and immunity

16. Rheumatoid Arthritis: The Role of Reactive Oxygen Species in Disease Development and Therapeutic Strategies

17. C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack

18. Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs

19. Tumor-Specific Inhibition of Membrane-Bound Complement Regulatory Protein Crry with Bispecific Monoclonal Antibodies Prevents Tumor Outgrowth in a Rat Colorectal Cancer Lung Metastases Model

20. CD55 expression patterns on intestinal neuronal tissue are divergent from the brain

21. Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation

22. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma

23. The NOX2-mediated ROS producing capacity of recipient cells is associated with reduced T cell infiltrate in an experimental model of chronic renal allograft inflammation

24. Subsets of human type 2 macrophages show differential capacity to produce reactive oxygen species

25. Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease

26. Differential IL-13 Production by Small Intestinal Leukocytes in Active Coeliac Disease versus Refractory Coeliac Disease

27. Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages

28. In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy

29. In Vitro-Generated DC with Tolerogenic Functions: Perspectives for In Vivo Cellular Therapy

30. Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice

31. Handbook of Experimental Pharmacology 'Dendritic Cells'

32. The protective role of ROS in autoimmune disease

33. Handbook of experimental pharmacology 'dendritic cells': the use of dexamethasone in the induction of tolerogenic DCs

34. Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo

35. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice

36. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species

37. FRI0374 Inflammatory Exosomes Implicate a Role for Epstein Barr Virus Infection in the Pathophysiology of Systemic Lupus Erythematosus

38. T cell surface redox levels determine T cell reactivity and arthritis susceptibility

39. Complement function in mAb-mediated cancer immunotherapy

40. Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model

41. Cytokines affect resistance of human renal tumour cells to complement-mediated injury

42. The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies

45. Beta-glucan enhanced killing of renal cell carcinoma micrometastases by monoclonal antibody G250 directed complement activation.

46. Circulating C1q levels in health and disease, more than just a biomarker

47. Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators

48. Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia

49. Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children